FOXP3 and melanoma: Interestingly, metastatic lesions of melanoma patients who responded to ipilimumab were enriched for FcγRIII-expressing CD68+ “inflammatory” macrophages prior to treatment, while intra-tumoral FoxP3+ Tregs were depleted following treatment.